Publications by authors named "M M H Lahr"

Memories are dynamic constructs whose properties change with time and experience. The biological mechanisms underpinning these dynamics remain elusive, particularly concerning how shifts in the composition of memory-encoding neuronal ensembles influence the evolution of a memory over time. By targeting developmentally distinct subpopulations of principal neurons, we discovered that memory encoding resulted in the concurrent establishment of multiple memory traces in the mouse hippocampus.

View Article and Find Full Text PDF

Background: The benefit of intravenous thrombolysis with alteplase before endovascular thrombectomy (EVT) for acute ischemic stroke due to large vessel occlusion remains debated. In this study, we analyzed the cost-effectiveness of EVT alone versus intravenous alteplase before EVT in patients directly admitted to EVT-capable stroke centers from the Dutch health care payer perspective.

Methods: A decision analysis was performed using a Markov model with 15-year simulated follow-up to estimate total costs, quality-adjusted life years, and an incremental cost-effectiveness ratio of intravenous alteplase before EVT compared with EVT alone.

View Article and Find Full Text PDF
Article Synopsis
  • Housing is crucial for health, and this study explores how governmental rental assistance varies between rural and urban areas, particularly focusing on health and disability factors.
  • Analysis of the 2021 National Health Interview Survey data reveals that rural renters are more likely to receive rental assistance compared to urban renters, despite a lower overall rental rate in rural areas.
  • Findings show that rural recipients of this assistance have higher rates of disability and poorer health, indicating a significant need for affordable housing solutions in both rural and urban contexts.
View Article and Find Full Text PDF

Introduction: Alteplase is widely used as an intravenous thrombolytic drug in acute ischemic stroke (AIS). Recently however, tenecteplase, a modified form of tissue plasminogen activator, has been shown to increase early recanalization rate and has proven to be non-inferior with a similar safety profile compared to alteplase. This study aims to evaluate the cost-effectiveness of 0.

View Article and Find Full Text PDF